Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1

BMC Musculoskeletal Disorders

Volumn 7, Issue , 2006, Pages

  Groeneweg, J George ^a   Huygen, Frank J P M ^a   Heijmans Antonissen, Claudia ^a   Niehof, Sjoerd ^a   Zijlstra, Freek J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; INTERLEUKIN 6; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ASPIRATION BIOPSY; BLISTER; CLINICAL ARTICLE; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; MALE;

ADULT; BIOLOGICAL MARKERS; BLISTER; DERMATITIS; DOWN-REGULATION; ENDOTHELIN-1; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MICROCIRCULATION; MIDDLE AGED; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; REFLEX SYMPATHETIC DYSTROPHY; REGIONAL BLOOD FLOW; SKIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33845500739     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-7-91     Document Type: Article

References (48)

1. Janig W, Baron R: Complex regional pain syndrome: mystery explained? Lancet Neurol 2003, 2(11):687-697.
2. Baron R, Janig W: Complex regional pain syndromes - how do we escape the diagnostic trap? Lancet 2004, 364(9447):1739-1741.
3. Bruehl S, Harden RN, Galer BS, Saltz S, Bertram M, Backonja M, Gayles R, Rudin N, Bhugra MK, Stanton-Hicks M: External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain 1999, 81(1-2):147-154.
4. Bruehl S, Harden RN, Galer BS, Saltz S, Backonja M, Stanton-Hicks M: Complex regional pain syndrome: are there distinct subtypes and sequential stages of the syndrome? Pain 2002, 95(1-2):119-124.
5. Huygen FJ, de Bruijn AG, Klein J, Zijlstra FJ: Neuroimmune alterations in the complex regional pain syndrome. Eur J Pharmacol 2001, 429(1-3):101-113.
6. Dijkstra PU, Groothoff JW, ten Duis HJ, Geertzen JH: Incidence of complex regional pain syndrome type I after fractures of the distal radius. Eur J Pain 2003, 7(5):457-462.
7. Mos M, Bruijn AGJ, Huygen FJPM, Dieleman JP, Stricker BHC, Sturkenboom MCJM: The incidence of Complex Regional Pain Syndrome: a population-based study. Submitted 2006.
8. Birklein F: Complex regional pain syndrome. J Neurol 2005, 252(2):131-138.
9. Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijlstra FJ: Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm 2002, 11(1):47-51.
10. Schwartzman RJ, Popescu A: Reflex sympathetic dystrophy. Curr Rheumatol Rep 2002, 4(2):165-169.
11. Wasner G, Heckmann K, Maier C, Baron R: Vascular abnormalities in acute reflex sympathetic dystrophy (CRPS I): complete inhibition of sympathetic nerve activity with recovery. Arch Neurol 1999, 56(5):613-620.
12. Wasner G, Schattschneider J, Heckmann K, Maier C, Baron R: Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain 2001, 124(Pt 3):587-599.
13. Baamonde A, Lastra A, Villazon M, Bordallo J, Hidalgo A, Menendez L: Involvement of endogenous endothelins in thermal and mechanical inflammatory hyperalgesia in mice. Naunyn Schmiedebergs Arch Pharmacol 2004, 369(2):245-251.
14. Dahlof B, Gustafsson D, Hedner T, Jern S, Hansson L: Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J Hypertens 1990, 8(9):811-817.
15. Oda M, Yokomori H, Han JY: Regulatory mechanisms of hepatic microcirculation. Clin Hemorheol Microcirc 2003, 29(3-4):167-182.
16. Leslie SJ, Rahman MQ, Denvir MA, Newby DE, Webb DJ: Endothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide. Br J Clin Pharmacol 2004, 57(6):720-725.
17. Huygen FJ, Niehof S, Zijlstra FJ, van Hagen PM, van Daele PL: Successful treatment of CRPS 1 with anti-TNF. J Pain Symptom Manage 2004, 27(2):101-103.
18. Alonso D, Radomski MW: The nitric oxide-endothelin-1 connection. Heart Fail Rev 2003, 8(1):107-115.
19. Yoshizumi M, Perrella MA, Burnett JC Jr., Lee ME: Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993, 73(1):205-209.
20. Patel JN, Jager A, Schalkwijk C, Corder R, Douthwaite JA, Yudkin JS, Coppack SW, Stehouwer CD: Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release. Clin Sci (Lond) 2002, 103(4):409-415.
21. Matsushima H, Yamada N, Matsue H, Shimada S: The effects of endothelin-1 on degranulation, cytokine, and growth factor production by skin-derived mast cells. Eur J Immunol 2004, 34(7):1910-1919.
22. Huygen FJ, Ramdhani N, Van Toorenenbergen A, Klein J, Zijlstra FJ: Mast cells are involved in inflammatory reactions during Complex Regional Pain Syndrome type 1. Immunol Lett 2004, 91(2-3):147-154.
23. Oerlemans HM, Oostendorp RA, de Boo T, van der Laan L, Severens JL, Goris JA: Adjuvant physical therapy versus occupational therapy in patients with reflex sympathetic dystrophy/complex regional pain syndrome type I. Arch Phys Med Rehabil 2000, 81(1):49-56.
24. Prens EP, Benne K, van Damme J, Bakkus M, Brakel K, Benner R, van Joost T: Interleukin-1 and interleukin-6 in psoriasis. J Invest Dermatol 1990, 95(6 Suppl):121S-124S.
25. Macdonald N, Cumberbatch M, Singh M, Moggs JG, Orphanides G, Dearman RJ, Griffiths CE, Kimber I: Proteomic analysis of suction blister fluid isolated from human skin. Clin Exp Dermatol 2006, 31(3):445-448.
26. Michiels JJ, Zijlstra FJ: Prostaglandin cyclooxygenase products but not thromboxane A2 are involved in the pathogenesis of erythromelalgia in thrombocythaemia. Mediators Inflamm 1993, 2:385 -3389.
27. Reilly DM, Green MR: Eicosanoid and cytokine levels in acute skin irritation in response to tape stripping and capsaicin. Acta Derm Venereol 1999, 79(3):187-190.
28. Heijmans-Antonissen C, Wesseldijk F, Munnikes RJ, Huygen FJ, van der Meijden P, Hop WC, Hooijkaas H, Zijlstra FJ: Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm 2006, 2006(1):28398.
29. Munnikes RJ, Muis C, Boersma M, Heijmans-Antonissen C, Zijlstra FJ, Huygen FJ: Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines. Mediators Inflamm 2005, 2005(6):366-372.
30. Bonifati C, Mussi A, Carducci M, Pittarello A, D'Auria L, Venuti A, Bagnato A, Salani D, Fazio M, Ameglio F: Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity. Acta Derm Venerol 1998, 78(1):22-26.
31. Eisenberg E, Erlich T, Zinder O, Lichinsky S, Diamond E, Pud D, Davar G: Plasma endothelin-1 levels in patients with complex regional pain syndrome. Eur J Pain 2004, 8(6):533-538.
32. El Melegy NT, Ali ME, Awad EM: Plasma levels of endothelin-1, angiotensin II, nitric oxide and prostaglandin E in the venous and cavernosal blood of patients with erectile dysfunction. BJU Int 2005, 96(7):1079-1086.
33. Pache M, Schwarz HA, Kaiser HJ, Wuest P, Kloti M, Dubler B, Flammer J: Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis. Med Sci Monit 2002, 8(9):616-619.
34. Haq A, El-Ramahi K, Al-Dalaan A, Al-Sedairy ST: Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis. J Med 1999, 30(1-2):51-60.
35. Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S, Ciolkiewicz M: A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis. Clin Rheumatol 2005:1-6.
36. Wakisaka N, Kubota T, Ando K, Aihara M, Inoue H, Ishida H: Endothelin-1 kinetics in plasma, urine, and blister fluid in burn patients. Ann Plast Surg 1996, 37(3):305-309.
37. Hartrick CT: Increased production of nitric oxide stimulated by interferon-gamma from peripheral blood monocytes in patients with complex regional pain syndrome. Neurosci Lett 2002, 323(1):75-77.
38. Alonso D, Radomski MW: Nitric oxide, platelet function, myocardial infarction and reperfusion therapies. Heart Fail Rev 2003, 8(1):47-54.
39. Erkan E, Devarajan P, Kaskel F: Role of nitric oxide, endothelin-1, and inflammatory cytokines in blood pressure regulation in hemodialysis patients. Am J Kidney Dis 2002, 40(1):76-81.
40. Oerlemans HM, Goris RJ, Oostendorp RA: Impairment level sumscore in reflex sympathetic dystrophy of one upper extremity. Arch Phys Med Rehabil 1998, 79(8):979-990.
41. Maeda S, Miyauchi T, Kakiyama T, Sugawara J, Iemitsu M, Irukayama-Tomobe Y, Murakami H, Kumagai Y, Kuno S, Matsuda M: Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans. Life Sci 2001, 69(9):1005-1016.
42. Tanabe K, Yamamoto A, Suzuki N, Yokoyama Y, Osada N, Nakayama M, Akashi Y, Seki A, Samejima H, Oya M, Murabayashi T, Omiya K, Itoh H, Miyake F, Murayama M: Physiological role of endothelin-1 in nonworking muscles during exercise in healthy subjects. Jpn Circ J 2000, 64(1):27-31.
43. Maeda S, Tanabe T, Miyauchi T, Otsuki T, Sugawara J, Iemitsu M, Kuno S, Ajisaka R, Yamaguchi I, Matsuda M: Aerobic exercise training reduces plasma endothelin-1 concentration in older women. J Appl Physiol 2003, 95(1):336-341.
44. Maeda S, Miyauchi T, Iemitsu M, Tanabe T, Irukayama-Tomobe Y, Goto K, Yamaguchi I, Matsuda M: Involvement of endogenous endothelin-1 in exercise-induced redistribution of tissue blood flow: an endothelin receptor antagonist reduces the redistribution. Circulation 2002, 106(17):2188-2193.
45. Malmstrom RE, Weitzberg E: Endothelin and nitric oxide in inflammation: could there be a need for endothelin blocking anti-inflammatory drugs? J Hypertens 2004, 22(1):27-29.
46. Nelson JB: Endothelin receptor antagonists. World J Urol 2005, 23:19 -127.
47. Girgis RE, Champion HC, Diette GB, Johns RA, Permutt S, Sylvester JT: Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy. Am J Respir Crit Care Med 2005, 172(3):352-357.
48. Meurs H, Maarsingh H, Zaagsma J: Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol Sci 2003, 24(9):450-455.